Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (281-290 of 770) with videos related to

Pageof 77
Sort By:
The American Journal of Medicine|July 23, 2002
An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinaseDavid M Kent, Rodney A Hayward, John L Griffith, et al.
JAMA|May 13, 2020
Rural-Urban Differences in Cardiovascular Mortality in the US, 1999-2017Sarah H Cross, Mandeep R Mehra, Deepak L Bhatt, et al.
BMJ Open|March 19, 2016
Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)Justin A Ezekowitz, Mohua Podder, Adrian F Hernandez, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 28, 2002
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trialsJames C Blankenship, Craig Balog, Shelly K Sapp, et al.
Circulation. Cardiovascular Quality and Outcomes|October 25, 2012
Evaluating the impact of public health notification: Duke clopidogrel experienceEric L Eisenstein, Daniel Wojdyla, Kevin J Anstrom, et al.
The New England Journal of Medicine|February 21, 2009
Ethical and scientific implications of the globalization of clinical researchSeth W Glickman, John G McHutchison, Eric D Peterson, et al.
Journal of the American College of Cardiology|October 2, 2002
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capabilityRajendra H Mehta, Douglas A Criger, Christopher B Granger, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2005
Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromesMary Ann Mascelli, Efthymios N Deliargyris, Lakshmi V Damaraju, et al.
American Heart Journal|April 29, 2006
Multifaceted intervention to promote beta-blocker use in heart failureNancy M Allen LaPointe, Elizabeth R DeLong, Anita Chen, et al.
JAMA|September 14, 2006
Peer-reviewed publication of clinical trials completed for pediatric exclusivityDaniel K Benjamin, Philip Brian Smith, M Dianne Murphy, et al.
Pageof 77

Showing results (281-290 of 770) with videos related to

Sort By:
Pageof 77
The American Journal of Medicine|July 23, 2002
An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinaseDavid M Kent, Rodney A Hayward, John L Griffith, et al.
JAMA|May 13, 2020
Rural-Urban Differences in Cardiovascular Mortality in the US, 1999-2017Sarah H Cross, Mandeep R Mehra, Deepak L Bhatt, et al.
BMJ Open|March 19, 2016
Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)Justin A Ezekowitz, Mohua Podder, Adrian F Hernandez, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 28, 2002
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trialsJames C Blankenship, Craig Balog, Shelly K Sapp, et al.
Circulation. Cardiovascular Quality and Outcomes|October 25, 2012
Evaluating the impact of public health notification: Duke clopidogrel experienceEric L Eisenstein, Daniel Wojdyla, Kevin J Anstrom, et al.
The New England Journal of Medicine|February 21, 2009
Ethical and scientific implications of the globalization of clinical researchSeth W Glickman, John G McHutchison, Eric D Peterson, et al.
Journal of the American College of Cardiology|October 2, 2002
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capabilityRajendra H Mehta, Douglas A Criger, Christopher B Granger, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2005
Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromesMary Ann Mascelli, Efthymios N Deliargyris, Lakshmi V Damaraju, et al.
American Heart Journal|April 29, 2006
Multifaceted intervention to promote beta-blocker use in heart failureNancy M Allen LaPointe, Elizabeth R DeLong, Anita Chen, et al.
JAMA|September 14, 2006
Peer-reviewed publication of clinical trials completed for pediatric exclusivityDaniel K Benjamin, Philip Brian Smith, M Dianne Murphy, et al.
Pageof 77